Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.1339
-0.0011 (-0.81%)
At close: Apr 30, 2026, 4:00 PM EDT
0.1220
-0.0119 (-8.89%)
Pre-market: May 1, 2026, 8:06 AM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.67 million as of May 1, 2026. Its market cap has decreased by -42.04% in one year.
Market Cap
2.67M
Enterprise Value
-232.11K
1-Year Change
-42.04%
Ranking
Category
Stock Price
$0.13
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.67M, a decrease of -98.71%. That is a compound annual growth rate of -68.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 2.67M | 3.92% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.24M |
| Jaguar Health | 3.20M |
| GeoVax Labs | 3.18M |
| Decoy Therapeutics | 2.95M |
| Valion Bio | 2.70M |
| HCW Biologics | 2.69M |
| Oragenics | 2.67M |
| Bone Biologics | 2.37M |